Novo Nordisk Archives -

Novo’s Ozempic gains MACE risk reduction label in US

https://pharmaphorum.com/news/novos-ozempic-gains-mace-risk-reduction-label-in-us/

Novo Nordisk joins with UVA in diabetes digital simulation project

https://pharmaphorum.com/news/novo-nordisk-joins-with-uva-in-diabetes-digital-simulation-project/

Novartis top of pile in European pharma in 2020, say Jefferies analysts

https://pharmaphorum.com/news/novartis-top-of-pile-in-european-pharma-say-jefferies-analysts/

Novo bolsters R&D pipeline with RNAi therapies from Dicerna

https://pharmaphorum.com/news/novo-bolsters-rd-pipeline-with-rnai-therapies-from-dicerna/

Novo Nordisk buys rights to NASH drug from Japan’s UBE

https://pharmaphorum.com/news/novo-nordisk-buys-rights-to-nash-drug-as/

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

https://pharmaphorum.com/news/novo-nordisk-builds-in-haemophilia-with-bluebird-bio-gene-editing-deal/

How to make digital adoption a smooth journey

https://pharmaphorum.com/views-analysis-sales-marketing/digital-adoption-smooth-journey/

Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome

https://pharmaphorum.com/news/novos-new-oral-glp-1-still-has-obstacles-to-overcome/

The Pharma Comms Impact Conference – For Internal & External

https://pharmaphorum.com/events/the-pharma-comms-impact-conference-for-internal-external/

Search